Immunotherapy With E6 T Cell Receptor (TCR) T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions
Condition(s):Human Papillomavirus; HPV-16; High Grade Squamous Intraepithelial LesionLast Updated:February 16, 2021Terminated
Hide Studies Not Open or Pending
Condition(s):Human Papillomavirus; HPV-16; High Grade Squamous Intraepithelial LesionLast Updated:February 16, 2021Terminated
Condition(s):High Grade Anal Canal Squamous Intraepithelial Neoplasia; Human Immunodeficiency VirusLast Updated:November 18, 2023Completed
Condition(s):High Grade Cervical Epithelial Neoplasia (CIN2+)Last Updated:November 30, 2016Completed
Condition(s):AIDS-Related Anal Carcinoma; AIDS-Related Cervical Carcinoma; High Grade Anal Intraepithelial Neoplasia; High Grade Cervical Intraepithelial Neoplasia; HIV InfectionLast Updated:March 6, 2024Recruiting
Condition(s):High Grade Squamous Intra-epithelial Lesion (HSIL)Last Updated:March 31, 2022Unknown status
Condition(s):Anal High-Grade Squamous Intraepithelial LesionsLast Updated:September 1, 2023Completed
Condition(s):Squamous Lntraepithelial Lesions of Vulva; Neoplasms, Squamous Cell; Vulvar HSILLast Updated:April 13, 2021Terminated
Condition(s):High-Grade Squamous Intraepithelial LesionsLast Updated:March 22, 2024Completed
Condition(s):Anal Cancer; Precancerous ConditionLast Updated:December 21, 2015Completed
Condition(s):Cervical Intraepithelial Neoplasia Grade 2/3Last Updated:August 12, 2022Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.